Joinn Laboratories(China)Co.,Ltd.

Total Valuation

Joinn Laboratories(China)Co.,Ltd. carries a market capitalization of 25.26B, placing it among publicly traded companies globally. Its enterprise value stands at 10.93B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Joinn Laboratories(China)Co.,Ltd. currently has 749.48M shares outstanding.

Valuation Ratios

Joinn Laboratories(China)Co.,Ltd. trades at a trailing price-to-earnings ratio of 42.85. The price-to-sales ratio is 7.11, and the price-to-book ratio stands at 4.53.

Enterprise Valuation

On an enterprise value basis, Joinn Laboratories(China)Co.,Ltd. trades at an EV/EBITDA multiple of 92.25 and an EV/FCF ratio of 47.47. The EV/Sales ratio of 5.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 92.25 provides insight into valuation relative to core operating earnings.

Financial Position

Joinn Laboratories(China)Co.,Ltd. maintains a current ratio of 4.52, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.50, indicating moderate leverage, while an interest coverage ratio of 59.98 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Joinn Laboratories(China)Co.,Ltd. posts a return on equity of 11.07 and a return on invested capital of 1.23.

Taxes

Over the trailing twelve months, Joinn Laboratories(China)Co.,Ltd. has paid 58.58M in income taxes, reflecting an effective tax rate of 16.21.

Stock Price Statistics

Joinn Laboratories(China)Co.,Ltd.'s stock has declined approximately -6.05906% over the past 52 weeks. The 50-day moving average sits at 18.93, while the 200-day moving average is 20.29.

Income Statement

Over the trailing twelve months, Joinn Laboratories(China)Co.,Ltd. generated 1.84B in revenue and converted that into 304.75M in net income, yielding earnings per share of 0.37. EBITDA reached 118.52M, while operating income came in at 118.52M.

Balance Sheet

Joinn Laboratories(China)Co.,Ltd. holds 2.17B in cash and equivalents against 40.57M in total debt, resulting in a net debt position of -662.23M. Total book value stands at 2.88B, with working capital of 4.11B providing operational flexibility.

Cash Flow

After subtracting -228.67M in capital expenditures, free cash flow totaled -228.67M - equivalent to -0.28 per share.

Margins

Joinn Laboratories(China)Co.,Ltd. operates with a gross margin of 25.93, reflecting its pricing power and cost economics. The operating margin of 6.45 and net profit margin of 16.58 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Joinn Laboratories(China)Co.,Ltd.'s most recent stock split took place on June 20, 2023 with a 5:7 split ratio.

Scores

Joinn Laboratories(China)Co.,Ltd. posts an Altman Z-Score of 6.85, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.